A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.
about
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activityEndostatin gene variation and protein levels in breast cancer susceptibility and severity.Genetic loci that control the size of laser-induced choroidal neovascularizationPolymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studiesRole of genetic polymorphisms in tumour angiogenesisCellular actions and signaling by endostatin.Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors.Gene variants in the angiogenesis pathway and prostate cancer.A high risk of osteosarcoma in individuals who are homozygous for the p.D104N in endostatinGenetic polymorphisms in COL18A1 influence the development of osteosarcoma.Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndromeGenetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma.Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent manner.
P2860
Q24652387-3E86D985-66F7-4FAA-8C4D-A3C2A7F54B7FQ33288626-992DF9FE-0CE4-4CF1-96B7-677828616A3BQ33411677-BD2E38CE-A553-487B-B55A-79172C61D062Q33726756-07D754F8-FAFE-4AA5-B2F6-271A575B2B1AQ34213827-44961337-D124-488E-B2A1-F656C779818DQ34981278-3AFEAA46-2488-4CF9-A29F-FA9BD55A0813Q35008096-A52626E0-5578-476C-B65D-2CDA5BAE4E4CQ35140747-A61D5898-D0E6-403E-A5B7-7A76ED650109Q35743934-37ABBCD4-5976-4EA3-944E-6F445FEB0FE0Q36118876-612EC7D3-A9AE-4822-866E-7559DE6C1271Q36254812-DBFE525D-2CCB-404A-A0BC-322B039AB7EDQ36261921-41739AA0-55A0-4BCC-A3C5-692919A4AA39Q37203797-8A4C53AF-6AD1-4473-AA58-AFB165C2D28BQ37482521-2478AED2-8C54-48FD-BA10-98B2EDAF7D05Q49568375-3BA94894-679B-4816-A75A-BF623B7CC4CFQ52609121-DF1820F0-CBD6-43D7-94E1-6E039A16F888
P2860
A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@ast
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@en
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@nl
type
label
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@ast
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@en
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@nl
prefLabel
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@ast
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@en
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@nl
P2093
P1433
P1476
A polymorphism in endostatin, ...... t of prostatic adenocarcinoma.
@en
P2093
Iughetti P
Moreira ES
Moreira-Filho CA
Passos-Bueno MR
P304
P407
P577
2001-10-01T00:00:00Z